Alpha Tau Medical Ltd (DRTS)
NASDAQ:DRTS
US Market
Holding DRTS?
Track your performance easily

Alpha Tau Medical Ltd (DRTS) Income Statement

93 Followers

Alpha Tau Medical Ltd Income Statement

Last quarter (Q4 2023), Alpha Tau Medical Ltd's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Alpha Tau Medical Ltd's net income was $―. See Alpha Tau Medical Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 418.93M---$ 0.00
Cost of Revenue
$ 367.73M----
Gross Profit
$ 51.20M----
Operating Expense
$ 48.79M$ 35.72M$ 32.14M$ 13.79M$ 9.24M
Operating Income
$ 2.42M$ -35.72M$ -32.14M$ -13.79M$ -9.24M
Net Non Operating Interest Income Expense
$ 2.83M$ 6.79M--$ 622.00K
Other Income Expense
$ -3.00M-$ 1.61M$ -13.47M$ -102.00K
Pretax Income
$ 8.80M$ -29.14M$ -33.74M$ 27.26M$ -8.72M
Tax Provision
$ 2.82M$ 16.00K$ 20.00K$ -7.00K$ 158.00K
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ 5.97M$ -29.16M$ -33.76M$ -309.00K$ -8.88M
Basic EPS
$ -0.04$ -0.42$ -0.53$ -0.67$ -0.13
Diluted EPS
$ -0.04$ -0.42$ -0.53$ -0.67$ -0.13
Basic Average Shares
$ 68.80M$ 69.38M$ 63.53M$ 40.53M$ 66.53M
Diluted Average Shares
$ 68.80M$ 69.38M$ 63.53M$ 40.53M$ 66.53M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 416.51M$ 35.72M$ 32.14M$ 13.79M$ 9.24M
Net Income From Continuing And Discontinued Operation
$ 5.97M$ -29.16M$ -33.76M$ -309.00K$ -8.88M
Normalized Income
$ 5.69M---$ -8.80M
Interest Expense
-----
EBIT
$ 4.05M-$ -33.74M$ 27.26M$ -9.24M
EBITDA
$ 8.19M-$ -32.76M$ 28.04M$ -9.16M
Currency in USD

Alpha Tau Medical Ltd Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis